4.7 Review

The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases

Journal

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
Volume 9, Issue 5, Pages 435-443

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/ijbs.6087

Keywords

c-kit receptor; signal transduction; tumor; targeted therapy

Funding

  1. Zhejiang Provincial Natural Science Foundation of China [LY12B02019]
  2. Public Technology Research and Social Development Project of Zhejiang Province [2011C23004]
  3. Qianjiang Talents Program of Zhejiang Province [2009R10002]
  4. Program for Zhejiang Leading Team of Science and Technology Innovation [2011R50021]

Ask authors/readers for more resources

As an important member of tyrosine kinase family, c-kit receptor causes specific expression of certain genes, regulates cell differentiation and proliferation, resists cell apoptosis, and plays a key role in tumor occurrence, development, migration and recurrence through activating the downstream signaling molecules following interaction with stem cell factor (SCF). The abnormality of SCF/c-kit signaling pathway is closely related to some certain tumors. The discovery of c-kit receptor-targeted drugs has promoted clinical-related cancer's diagnosis and treatment. In this paper, we review recent research progress on c-kit receptor-mediated signal transduction and its potential therapeutic application as a target in tumor-related diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available